Skip to main content
Log in

Growth hormone response to oral clonidine test in normal and short children

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

We evaluated the growth hormone (GH) response to an acute Clonidine test (0.15 mg/m2 po) in 30 normal prepubertal children (stature between the 3rd and 97th centile), in 29 short children (stature <3rd centile for age) with height velocity (HV) >10th centile and in 20 short children with HV <10th centile. The three groups had comparable chronological ages. After clonidine administration mean peak GH levels were similar in the three groups (19.4±9.8, 17.7±8.8 and 14.6±8.9 μg/l, mean±SD, respectively). By chosing 10 μg/l as the limit for a normal response we found that stimulated GH levels had a sensitivity of 50% and a specificity of 83% in identifying children with suspected GHD (short children with subnormal HV). The diagnostic accuracy was almost superimposable, for cutoff values of 10 and 12 μg/l. Eight of the 10 children with subnormal HV and a GH peak <10 μg/l had a GH peak <10 μg/l also after a second stimulation test. Six of the 29 short children with normal HV had a GH peak <10 μg/l. Only one of them had a GH peak <10 μg/l after a second stimulation test. Five of the normal children had peak GH levels <10 μg/l. These results indicate that HV is a useful variable to predict the GH response to an acute GH stimulus, since the great majority of children with a normal growth rate had a normal GH response to at least one stimulation test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Spiliotis B.E., August G.P., Hung W., Sonis W., Mendelson W., Bercu B.B. Growth hormone neurosecretory dysfunction: a treatable cause of short stature. JAMA 251: 2223, 1984.

    Article  CAS  PubMed  Google Scholar 

  2. Zadik Z., Chalew S.A., Raiti S., Kowarski A.A. Do short children secrete insufficient growth hormone? Pediatrics 76: 355, 1985.

    CAS  PubMed  Google Scholar 

  3. Rose S.R., Ross J.L., Uriarte M., Barnes K., Cassorla F.G., Cutler G.B. The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N. Engl. J. Med. 319: 201, 1988.

    Article  CAS  PubMed  Google Scholar 

  4. Lanes R. Diagnostic limitations of spontaneous growth hormone measurements in normally growing prepubertal children. Am. J. Dis. Child. 143: 1284, 1989.

    CAS  PubMed  Google Scholar 

  5. Zadik Z., Chalew S.A., Kowarski A. Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation. J. Clin. Endocrinol. Metab. 71: 932, 1990.

    Article  CAS  PubMed  Google Scholar 

  6. Gil-Ad I., Topper E., Laron Z. Oral Clonidine as a growth hormone stimulation test. Lancet 2: 278, 1979.

    Article  CAS  PubMed  Google Scholar 

  7. Fraser N.C., Seth J., Brown N.S. Clonidine is a better test for growth hormone deficiency than insulin hypoglycaemia. Arch. Dis. Child. 58: 355, 1983.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Dattani M.T., Pringle P.J., Hindmarsh P.C., Brook C.G.D. What is a normal stimulated growth hormone concentration? J. Endocrinol. 133: 447, 1992.

    Article  CAS  PubMed  Google Scholar 

  9. Albertson-Wikland K., Rosberg S. Analyses of 24-hour growth hormone profiles in children: relation to growth. J. Clin. Endocrinol. Metab. 67: 493, 1988.

    Article  Google Scholar 

  10. Underwood L.E., D’Ercole A.J., Van Wyk J.J. Somatomedin-C and the assessment of growth. Pediatr. Clin. North Am. 27: 771, 1980.

    CAS  PubMed  Google Scholar 

  11. Lee P.D.K., Wilson D.M., Rountree L., Hinz R.L., Rosenfeld R.G. Efficacy of insulin-like growth factor I levels in predicting the response to provocative growth hormone testing. Pediatr. Res. 27: 45, 1990.

    Article  CAS  PubMed  Google Scholar 

  12. Rudman D., Kutner M.H., Chawla R.K. The short child with subnormal plasma somatomedin C. Pediatr. Res. 19: 975, 1985.

    Article  CAS  PubMed  Google Scholar 

  13. Rosenfeld R.G., Wilson D.M., Lee P.D.K., Hinz R.L. Insulin-like growth factors I and II in evaluation of growth retardation. J. Pediatr. 109: 428, 1986.

    Article  CAS  PubMed  Google Scholar 

  14. Oerter K.E., Sobel A.M., Rose S.R., Cristiano A., Malley J.D., Cutler G.B. jr., Baron J. Combining insulin-like growth factor-I and mean spontaneous nighttime growth hormone levels for the diagnosis of growth hormone deficiency. J. Clin. Endocrinol Metab. 75: 1413, 1992.

    CAS  PubMed  Google Scholar 

  15. Dammacco F., Boghen M., Camanni F., Cappa M., Ferrari C., Ghigo E., Giordano G., Loche S., Minuto F., Mucci M., Müller E.E. Somatotropic function in short stature. Evaluation by integrated auxological and hormonal indices in 214 children. J. Clin. Endocrinol. Metab., 77: 68, 1993..

    CAS  PubMed  Google Scholar 

  16. Brook C.G.D. Treatment of growth deficiency. Clin. Endocrinol. (Oxf.) 30: 197, 1988.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loche, S., Cappa, M., Ghigo, E. et al. Growth hormone response to oral clonidine test in normal and short children. J Endocrinol Invest 16, 899–902 (1993). https://doi.org/10.1007/BF03348953

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348953

Key-words

Navigation